Ypsomed Holding AG (0QLQ.L)
LSE · CHF
CHF 388.60 (+0.41%) as of
Key statistics
- P/E (TTM)
- 212.70
- EPS (TTM)
- 1.83
- 52-week range
- 179.00 – 388.80
- Beta
- 0.81
- Revenue (TTM)
- 730.98M
- Profit margin
- 30.36%
- Volume
- 62.00
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
- Headquarters
- Burgdorf, Switzerland
- Employees
- 2,025
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.